Circular RNA biomarkers in cardiovascular disease
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Circular RNAs (circRNAs) show promise as stable biomarkers for heart disease detection and treatment. Their unique structure offers advantages over current markers, aiding in diagnosis and prognosis.
Area Of Science
- Cardiovascular Biology
- RNA Biology
- Biomarker Discovery
Background
- Heart disease remains a leading global cause of mortality.
- Existing biomarkers like troponins and BNP have limitations (e.g., transient nature, variability).
- Need for novel, stable biomarkers reflecting underlying cardiac pathology is critical.
Purpose Of The Study
- To review the role of circular RNAs (circRNAs) in cardiovascular disease.
- To explore circRNAs as potential diagnostic and prognostic biomarkers.
- To discuss challenges and future directions for clinical application of circRNAs in heart conditions.
Main Methods
- Literature review of recent scientific discoveries on circRNAs in heart disease.
- Analysis of circRNA formation, function, and stability.
- Examination of clinical potential and implementation hurdles.
Main Results
- Circular RNAs are stable, noncoding RNA molecules with unique closed structures.
- circRNAs are implicated in gene regulation and cardiac disease development.
- Their tissue-specific expression and cross-species conservation highlight their biomarker potential.
Conclusions
- circRNAs represent a promising class of biomarkers for heart disease diagnosis and prognosis.
- Their stability and regulatory roles offer advantages over conventional markers.
- Further research is needed to translate circRNA findings into clinical practice for cardiovascular conditions.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...